This is likely due to several factors; each of the NPC lines had different levels of NCC and other cell type contaminants at baseline, resulting in wide variability in initial gene expression profiles and thus also in the extent of improvement and change in NPC quality following sorting. The gene discussed is SLC12A3; the disease is nasopharyngeal carcinoma.